BRAF and thyroid cancer: Recent studies have demonstrated that abnormal production of MMPs and inflammatory factors is a main mechanism by which BRAF mutations promote the pathogenesis of thyroid cancer [119], with TGF‐β1 playing a pivotal role in this process [121, 140].